New Providers on Science Exchange: Predictive Models and Analytical Tools for Translational Research

translational-research

If you aren’t exploring the latest cell culture models of human tissue for nonclinical and preclinical testing, you should be. That’s the bottom line of today’s Science Exchange service provider roundup — three of the five newest service providers on our platform are experts in developing predictive models. Advances in predictive model systems Axiogenesis, based […]

Read More…

Small Biotech Stories: Eos Neuroscience

neuroscience

Eos Neuroscience is a company built on collaboration, featuring a unique team with expertise in transgenes, virology and gene expression, and retinal degeneration. Once they complete their preclinical stage, their intended userbase would be those with blindness attributed to photoreceptor degeneration, or age-related macular degeneration. They are running into some problems in the process of […]

Read More…

Guest post: At the core of cancer research, shared resources accelerate translation

biomolecular

This is a guest post by Deborah Berry, Co-Director for the Histopathology and Tissue Shared Resource (HTSR) at Lombardi Cancer Center (full bio below).  One of my colleagues at the Georgetown University Medical Center, Todd Waldman, is studying the genes that cause glioblastoma multiforme (GBM).  GBM is the most common and deadly form of primary […]

Read More…